These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8207119)

  • 1. Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1994 Jun; 52(1):33-40. PubMed ID: 8207119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.
    Puccioni-Sohler M; Rieckmann P; Kitze B; Lange P; Albrecht M; Felgenhauer K
    J Neurol; 1995 Mar; 242(4):239-42. PubMed ID: 7798123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
    Patzold T; Sindern E; Ossege-Pohle L; Malin JP
    J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
    J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
    Matsuda M; Tsukada N; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jun; 59(1-2):35-40. PubMed ID: 7541057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
    Hintzen RQ; Paty D; Oger J
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy.
    Kuroda Y; Matsui M; Takashima H; Kurohara K
    J Neuroimmunol; 1993 Jun; 45(1-2):133-6. PubMed ID: 8331158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy.
    Tsujino A; Nakamura T; Furuya T; Goto H; Nishiura Y; Shirabe S; Nakane S; Motomura M; Nagataki S
    J Neurol Sci; 1998 Feb; 155(1):76-9. PubMed ID: 9562326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal fluid analysis and the pathogenesis of central nervous system infection by HTLV-I].
    Puccioni-Sohler M
    Arq Neuropsiquiatr; 1997 Mar; 55(1):144-8. PubMed ID: 9332576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
    Geppert A; Losy J
    Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    Neurology; 1993 Dec; 43(12):2679-82. PubMed ID: 8255476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin in the sera of patients with multiple sclerosis and human lymphotropic virus type-1-associated myelopathy.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1995 Jan; 56(1):113-6. PubMed ID: 7822477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishimoto N; Yoshizaki K; Eiraku N; Machigashira K; Tagoh H; Ogata A; Kuritani T; Osame M; Kishimoto T
    J Neurol Sci; 1990 Jul; 97(2-3):183-93. PubMed ID: 2401896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
    Magliozzi R; Pezzini F; Pucci M; Rossi S; Facchiano F; Marastoni D; Montagnana M; Lippi G; Reynolds R; Calabrese M
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N; Yone K
    J Neurol Sci; 1991 Aug; 104(2):230-4. PubMed ID: 1940977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
    Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
    Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
    Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Ohta M; Ohta K; Nishimura M; Saida T
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.
    Puccioni-Sohler M; Kitze B; Felgenhauer K; Graef IT; Lange P; Novis S; Reiber H; Vaz B
    Arq Neuropsiquiatr; 1995 Dec; 53(4):760-5. PubMed ID: 8729769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.